The Aakaar Medical Technologies IPO is creating significant buzz in the Indian stock market as one of the most anticipated IPO launches of June 2025. This aesthetic medical company is preparing to go public with a fresh issue worth ₹27 crores, targeting investors interested in the rapidly growing cosmetic and medical device sector.
Are you wondering whether the Aakaar Medical Technologies IPO is worth your investment? With the subscription opening on June 20, 2025, time is running out to make an informed decision. This comprehensive guide will provide you with everything you need to know about this IPO – from pricing details to financial analysis and investment recommendations.
Let’s dive deep into what makes this IPO tick and whether it deserves a place in your investment portfolio.
What is Aakaar Medical Technologies Limited?
Aakaar Medical Technologies Limited is a specialized aesthetic medical company incorporated in June 2013. The company has established itself as a significant player in India’s cosmetic and medical device industry, serving a diverse clientele of dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists.
Core Business Operations
The company operates through a comprehensive business model that includes:
- Manufacturing and Distribution: Both domestic manufacturing and international sourcing
- Product Portfolio: Specialized cosmetic products and advanced medical devices
- Geographic Reach: Pan-India presence through trained sales and service engineers
- Target Market: Healthcare professionals in the aesthetic medicine sector
Product Range and Offerings
Aakaar Medical Technologies offers an extensive range of products across multiple categories:
Professional Medical Equipment
- Tattoo removal devices
- Pigmentation treatment equipment
- Skin rejuvenation devices
- Laser hair reduction systems
- Hair transplant devices
- Urinary incontinence treatment devices
Skincare and Cosmetic Products
- Professional skincare products
- Homecare skincare solutions
- Injectable and contouring products
- Hair growth serums and tablets
- Anti-hair loss solutions
- Medifacial kits
The company sources products from multiple international markets including South Korea, Spain, Italy, and Austria, ensuring access to cutting-edge technology and high-quality products.
Aakaar Medical Technologies IPO Details
Key IPO Information
| Parameter | Details |
|---|---|
| IPO Size | ₹27.00 Crores |
| Issue Type | Book Building (Fresh Issue Only) |
| Total Shares | 37,50,400 shares |
| Face Value | ₹10 per share |
| Price Band | ₹68 to ₹72 per share |
| Lot Size | 1,600 shares |
| Listing Exchange | NSE SME |
Important Dates and Timeline
The Aakaar Medical Technologies IPO follows a tight schedule that investors must be aware of:
| Event | Date |
|---|---|
| IPO Opening Date | Friday, June 20, 2025 |
| IPO Closing Date | Tuesday, June 24, 2025 |
| Allotment Date | Wednesday, June 25, 2025 |
| Refund Initiation | Thursday, June 26, 2025 |
| Credit to Demat | Thursday, June 26, 2025 |
| Listing Date | Friday, June 27, 2025 |
| UPI Mandate Cut-off | 5 PM on June 24, 2025 |
Investment Requirements
Understanding the minimum investment requirements is crucial for different investor categories:
For Retail Investors
- Minimum Investment: ₹1,08,800 (at lower price band)
- Recommended Investment: ₹1,15,200 (at cut-off price)
- Maximum Lots: 1 lot only
- Total Shares: 1,600 shares
For HNI (High Net Worth Individuals)
- Minimum Investment: ₹2,30,400
- Minimum Lots: 2 lots
- Total Shares: 3,200 shares
Share Allocation and Reservation
The Aakaar Medical Technologies IPO follows standard SME IPO allocation norms:
| Investor Category | Allocation |
|---|---|
| QIB (Qualified Institutional Buyers) | Not more than 50% of Net Issue |
| Retail Investors | Not less than 35% of Net Issue |
| NII (Non-Institutional Investors/HNI) | Not less than 15% of Net Issue |
Market Maker Allocation
- Market Maker: Alacrity Securities Ltd.
- Reserved Shares: 1,88,800 shares
Financial Performance Analysis
Revenue and Profitability Trends
The Aakaar Medical Technologies financial performance shows impressive growth trajectory:
| Financial Year | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Revenue (₹ Cr) | 32.88 | 46.27 | 61.76 |
| PAT (₹ Cr) | 2.15 | 2.87 | 6.04 |
| Total Assets (₹ Cr) | 23.23 | 34.01 | 51.85 |
| Net Worth (₹ Cr) | 9.66 | 12.53 | 23.20 |
Key Growth Metrics
- Revenue Growth (FY24 to FY25): 33% increase
- PAT Growth (FY24 to FY25): 110% increase
- Asset Growth: Consistent expansion year-over-year
Key Performance Indicators (KPIs)
The company’s financial health can be assessed through these critical metrics:
| KPI | Value |
|---|---|
| ROCE | 21.02% |
| Debt/Equity Ratio | 0.98 |
| Return on Net Worth | 33.81% |
| PAT Margin | 9.81% |
| EBITDA Margin | 15.81% |
| Price to Book Value | 5.23 |
Earnings Per Share Analysis
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS (₹) | 5.79 | 4.26 |
| P/E Ratio | 12.43 | 16.90 |
IPO Utilization of Funds
The Aakaar Medical Technologies IPO proceeds will be utilized strategically:
| S.No. | Purpose | Amount (₹ Crores) |
|---|---|---|
| 1 | Funding Working Capital Requirements | 20.35 |
| 2 | General Corporate Purposes | Remaining Amount |
Working Capital Focus
The majority of funds (₹20.35 crores) will be directed toward working capital requirements, indicating the company’s focus on:
- Inventory management
- Operational expansion
- Market penetration
- Service enhancement
Management and Promoter Details
Promoter Information
- Key Promoters: Dilip Ramesh Meswani and Bindi Dilip Meswani
- Pre-IPO Holding: 91.11% of total shareholding
- Post-IPO Holding: Will be diluted (exact percentage to be calculated)
IPO Intermediaries
| Role | Company |
|---|---|
| Book Running Lead Manager | Indorient Financial Services Ltd |
| Registrar | Bigshare Services Pvt Ltd |
| Market Maker | Alacrity Securities Ltd |
Investment Analysis and Expert Opinion
“AMTL is dealing in a wide range of aesthetics products and related devices. It posted growth in its top and bottom lines for the reported periods. The sudden boost in top and bottom lines in a pre-IPO year i.e., FY25 raise eyebrows and concern over its sustainability going forward.”
Key Investment Considerations
Positive Factors
- Growing Market: Aesthetic medicine is a rapidly expanding sector in India
- Diversified Portfolio: Wide range of products and devices
- Pan-India Presence: Established distribution network
- Strong Financial Growth: Impressive revenue and profit growth
- Experienced Management: Decade-long industry experience
Risk Factors
- Aggressive Pricing: Issue appears aggressively priced based on current valuations
- Sustainability Concerns: Sudden boost in FY25 financials raises questions
- SME Listing: Higher volatility compared to main board listings
- Market Dependence: Reliance on healthcare professional adoption
Competitive Landscape and Market Position
Industry Strengths
Aakaar Medical Technologies has built competitive advantages through:
- Experienced Management Team: Leadership with deep industry knowledge
- Diversified Customer Base: Serving multiple healthcare specialties
- Comprehensive Product Range: Both indigenous and international products
- Pan-India Reach: Extensive distribution through consignment partners
- Technical Support: 90 trained sales and service engineers
Geographic Presence
The company operates across major Indian states including:
- North: Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh
- East: Bihar, West Bengal, Assam
- West: Gujarat, Maharashtra
- Central: Madhya Pradesh
- South: Karnataka, Telangana, Tamil Nadu
Should You Invest in Aakaar Medical Technologies IPO?
Investment Recommendation
Based on comprehensive analysis, here’s our investment perspective:
For Conservative Investors
- Recommendation: Avoid or Wait
- Reason: Aggressive pricing and sustainability concerns about recent financial boost
For Moderate Risk Investors
- Recommendation: Small Allocation Only
- Reason: Good business model but valuation concerns persist
For Aggressive/High-Risk Investors
- Recommendation: Moderate Investment
- Reason: Growth potential in aesthetic medicine sector, but with caution
Key Decision Factors
Before investing in the Aakaar Medical Technologies IPO, consider:
- Your Risk Appetite: SME IPOs carry higher volatility
- Investment Horizon: Long-term perspective recommended
- Portfolio Allocation: Don’t exceed 2-3% of total portfolio
- Market Conditions: Current market sentiment and sectoral trends
How to Apply for Aakaar Medical Technologies IPO
Application Process
- Through Online Banking: UPI-based applications
- Through Broker Platforms: ASBA facility
- Bank Branch: Traditional application method
Required Documents
- PAN Card
- Demat Account Details
- Bank Account Information
- UPI ID (for UPI applications)
Application Tips
- Bid at Cut-off Price: To avoid rejection due to oversubscription
- Complete KYC: Ensure all documentation is current
- Check UPI Limits: Verify daily transaction limits
- Apply Early: Avoid last-minute technical issues
Open Your Trading Account for IPO Investment
Ready to invest in IPOs? Open your trading and demat account with top brokers:
Recommended Brokers
Free Trading and Demat Account on Dhan
- Zero brokerage on delivery trades
- Advanced IPO application features
- User-friendly mobile app
Free Trading and Demat Account on Zerodha
- India’s largest discount broker
- Comprehensive IPO platform
- Excellent research tools
Related IPO Investment Opportunities
Explore other upcoming IPO opportunities to diversify your investment portfolio:
- Arisinfra Solutions IPO 2025: Complete Investment Guide
- Eppeltone Engineers IPO 2025: Complete Investment Guide
- Patil Automation IPO 2025: Complete Investment Guide
- Aten Papers & Foam IPO 2025: Complete Investment Guide
Frequently Asked Questions (FAQ)
Conclusion
The Aakaar Medical Technologies IPO presents an interesting investment opportunity in India’s growing aesthetic medicine sector. While the company demonstrates strong financial growth and has established a solid market presence, the aggressive pricing and concerns about sustainability of recent financial performance warrant careful consideration.
For investors considering this IPO, remember that SME listings typically experience higher volatility and require a long-term investment perspective. The aesthetic medicine industry is undoubtedly growing, but success will depend on the company’s ability to maintain its growth trajectory and market position.
Key Takeaway: If you decide to invest in the Aakaar Medical Technologies IPO, limit your exposure to a small percentage of your portfolio and be prepared for potential volatility. The company’s fundamentals are decent, but the valuation concerns cannot be ignored.
Are you planning to apply for this IPO? Make sure to complete your research, assess your risk tolerance, and make an informed investment decision. Remember, successful IPO investing requires patience, research, and disciplined portfolio management.
